LSP Dementia Fund
Investments range between 5 million EUR and 25 million EUR.
LSP Dementia Fund seeks to invest in innovative companies focusing on neurodegenerative diseases with dementia, that have products or technologies that target underlying neurodegenerative processes or its symptoms and signs. LSP Dementia Fund's geographical focus is primarily Europe and the US.
- Status
Active
- Launch
2020
- Size
273M EUR
- SFDR classification
Art. 8
LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands
Company Registration Number: 34296447
LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.
Investment advisory commitee
Chairperson
Prof. dr Huibert Pols, emiritus Professor of Internal Medicine
Head of Fund
Partner and Head of Dementia Fund
Company | Sector | Market | Entry | Exit |
|---|---|---|---|---|
| Asceneuron | Healthcare | Switzerland | 2024 | - |
| AstronautX | Healthcare | United Kingdom | 2023 | - |
| Atalanta Therapeutics | Life Sciences | United States | 2024 | - |
| AviadoBio | Healthcare | United Kingdom | 2021 | - |
| Muna Therapeutics | Life Sciences | Denmark | 2021 | - |
| New Amsterdam Pharma | Life Sciences | Netherlands | 2021 | - |
| Nobi | Life Sciences | Belgium | 2022 | - |
| QurAlis | Healthcare | United States | 2022 | - |
| VectorY | Life Sciences | Netherlands | 2023 | - |
- Asceneuron
- CompanyAsceneuron
- SectorHealthcare
- MarketSwitzerland
- Entry2024
- Exit-
- AstronautX
- CompanyAstronautX
- SectorHealthcare
- MarketUnited Kingdom
- Entry2023
- Exit-
- Atalanta Therapeutics
- CompanyAtalanta Therapeutics
- SectorLife Sciences
- MarketUnited States
- Entry2024
- Exit-
- AviadoBio
- CompanyAviadoBio
- SectorHealthcare
- MarketUnited Kingdom
- Entry2021
- Exit-
- Muna Therapeutics
- CompanyMuna Therapeutics
- SectorLife Sciences
- MarketDenmark
- Entry2021
- Exit-
- New Amsterdam Pharma
- CompanyNew Amsterdam Pharma
- SectorLife Sciences
- MarketNetherlands
- Entry2021
- Exit-
- Nobi
- CompanyNobi
- SectorLife Sciences
- MarketBelgium
- Entry2022
- Exit-
- QurAlis
- CompanyQurAlis
- SectorHealthcare
- MarketUnited States
- Entry2022
- Exit-
- VectorY
- CompanyVectorY
- SectorLife Sciences
- MarketNetherlands
- Entry2023
- Exit-
Do You Want to Learn More?
We are eager to explore how we can achieve great things together.